Comparison 23. Erythropoietin stimulating agents: normal versus high haemoglobin target.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
23.1 Fatigue	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
23.1.1 Haemodialysis	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
23.2 Change in fatigue	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
23.2.1 Haemoglobin	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
23.3 Vitality	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
23.3.1 Haemodialysis	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
23.4 Change in vitality	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
23.4.1 Haemodialysis	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
23.5 Death (any cause)	3	1086	Risk Ratio (M‐H, Random, 95% CI)	1.05 [0.71, 1.56]
23.5.1 Haemodialysis	3	1035	Risk Ratio (M‐H, Random, 95% CI)	1.11 [0.73, 1.68]
23.5.2 Peritoneal dialysis	1	51	Risk Ratio (M‐H, Random, 95% CI)	0.61 [0.17, 2.17]
23.6 Cardiovascular death	1	344	Risk Ratio (M‐H, Random, 95% CI)	1.30 [0.68, 2.48]
23.6.1 Haemodialysis	1	293	Risk Ratio (M‐H, Random, 95% CI)	1.56 [0.75, 3.26]
23.6.2 Peritoneal dialysis	1	51	Risk Ratio (M‐H, Random, 95% CI)	0.73 [0.19, 2.74]
23.7 Cardiovascular events (angina pectoris, myocardial infarction, pulmonary oedema or cardiac failure)	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.7.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.8 Arteriovenous access thrombosis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.8.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.9 Hypertension	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.9.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.10 Myocardial infarction	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.10.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.11 Congestive heart failure	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.11.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.12 Permanent catheter thrombosis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.12.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.13 Arterious graft loss	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.13.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.14 Arterious fistula thrombosis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.14.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.15 Arterious fistula loss	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.15.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.16 Permanent catheter loss	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
23.16.1 Haemodialysis	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected